A small group of Mayne Pharma holders reckons US bidder Cosette's $600 million tilt does not capture the upside of ... Read ...

Eid-ul-Fitr is celebrated across the world on different days and it is determined by the sighting of the crescent moon which ...

U.S. stock indices slump amid tariff talks while healthcare sees major developments: J&J faces a $1.6B lawsuit, new FDA approvals, and a $2B ...

Novo Nordisk may miss sales expectations; federal judge fines Johnson & Johnson $1.64 billion in marketing case; CureVac mRNA ...

The American stock markets have had a rough month as investors remain jittery over international tariff fears. While this market downturn has affected most sectors of the economy, healthcare stocks ...

Health-care companies fell, but not by as much as the broad market, amid a rotation into defensive sectors. Shares of obesity-drug makers and biotech firms, which are engaged in higher-risk activities ...

Five years after COVID-19 reached pandemic status, public health experts reflect on what we learned—and how those lessons can ...

While 83% of healthcare executives are piloting generative AI, fewer than 10% have the infrastructure necessary for ...

FinOps, a relatively new discipline that makes it easier to analyze and measure cloud costs, will play an outsized role for ...

Healthcare trends in 2025 are transforming strategic planning, workforce dynamics, and rural healthcare access. David Willis discusses what’s next for the industry.

CoreWeave's IPO priced lower than expected, at $40 per share, raising $1.5B and valuing it at $19B - SiliconANGLE ...

The global Smart Pills Market ,valued at US$0.61 billion in 2023, is forecasted to grow at a robust CAGR of 11.2%, reaching US$0.69 billion ...